GreenSky (NASDAQ: GSKY) To Release $124.78M Quarterly Sales

GSK
GSK

The equities analysts are expecting GreenSky (NASDAQ: GSKY) to issue their quarterly sales that will be $124.78M for this present year on 10th March. 4 analysts estimated sales ranging between $123.31M and $127.60M. GreenSky posted $133.84M sales last year during this quarter, indicating a 6.8% negative annualized rate of growth.

Zacks analysts anticipate $520.92M full-year sales for the ongoing year that ranges between $519.47M and $523.75M. They expect $583.88M sales next year, ranging between $579.20M and $588.24M.

On Friday, the GreenSky company started from $6.07 with the market cap being $1.11B. They have a 121.42 PE ratio, 1.17 PEG ratio, and 1.67 betas. Their lowest in 52 weeks is $3.05 while the highest is $7.31. Their 50 day rolling average is $5.45 while 200 days is $4.72.

Market Undertakings Of GSKY Stock

Morgan Stanley demoted the price objective of GSKY shares to $4.50 from $5 and gave a rating of ‘equal weight’ on 16th November. Smith Citigroup decreased it to $3.50 from $4 on 16th November. Wolfe Research assigned a rating of ‘underperform’ on 6th November. Zacks Research promoted the rating to ‘hold’ from ‘sell’ on 2nd March, Tuesday. 4 research analysts allotted a rating of ‘sell’, and 6 assigned it a rating of ‘hold’. The firm has an average ‘hold’ recommendation with a $4.10 average price objective.

Dimensional Advisors increased the holdings on GSKY stock by nearly $139.5% and owns $285,000 worth of shares. UBS O’Connor upgraded their stake by roughly 31.4%, owning shares priced at $32,196,000. JPMorgan Chase and Company promoted their position by approximately 186.5%, owning $1,149,000 worth of shares. Walleye Trading upgraded their stake by almost 137.4% and own shares priced at $3,067,000. Walleye Capital raised its position by nearly 164%, owning $6,321,000 worth of shares. 35.53% GSKY stock is owned by hedge funds and institutional investors.